Acute Heart Failure and Coronary Blood Flow in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: An Observational Cohort Study
- PMID: 38205479
- PMCID: PMC10781414
- DOI: 10.7759/cureus.50340
Acute Heart Failure and Coronary Blood Flow in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: An Observational Cohort Study
Abstract
Background and objective The Global Registry of Acute Coronary Events (GRACE) study showed poor outcomes in ST-elevation myocardial infarction (STEMI) patients with acute heart failure (AHF) at hospital admission in terms of increased in-hospital and six-month mortality and readmission rates. In this study, we aimed to examine the effects of AHF at the time of admission on the coronary thrombus burden and post-primary percutaneous coronary intervention (PPCI) coronary flow among STEMI patients. Methods We conducted a cohort study involving 210 consecutive STEMI patients who presented to a single PPCI centre between June 2016 and January 2017. We classified them into two groups based on their Killip class at the time of presentation to the emergency department: no heart failure (NHF) and AHF groups. The primary outcome was the incidence of Thrombolysis In Myocardial Infarction (TIMI) flow grade of less than 3 in the stented coronary artery in the absence of mechanical obstruction or dissection (also known as no-reflow). The secondary outcome was the presence of a heavy thrombus burden (TIMI grade 4 or 5) at the time of angiography. Results The AHF group had a significantly higher incidence of no-reflow than the NHF group (25% vs. 8.4%, p=0.019). However, the prevalence of heavy thrombus burden did not differ significantly between the two groups (50% in the AHF group vs. 43.16% in the NHF group, p=0.557). The multivariable logistic regression analysis showed that AHF was an independent predictor of no-reflow in STEMI patients post-PPCI [Odds ratio (OR): 3.59, 95% confidence interval (CI): 1.09-11.83, p=0.035]. Conclusion Based on our findings, AHF is associated with an increased risk of no-reflow in STEMI patients post-PPCI, irrespective of the coronary thrombus load.
Keywords: coronary flow; killip; neurohumoral; no-reflow; perfusion; stemi; thrombus.
Copyright © 2023, Elkammash et al.
Conflict of interest statement
The first and corresponding author (Dr Amr Elkammash) worked as a Cardiology specialist in the International Cardiac Center, Alexandria, Egypt, at the time when the study was carried out, and his current affiliation represents his most recent place of work. The study’s abstract was presented at the Acute Cardiovascular Care Conference held in Marseille, France in 2023, and was published in the ESC Acute Cardiovascular Care journal supplement in May 2023. However, the detailed manuscript has never been published before.
Figures


Similar articles
-
Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Heart Vessels. 2019 Oct;34(10):1600-1607. doi: 10.1007/s00380-019-01399-w. Epub 2019 Apr 16. Heart Vessels. 2019. PMID: 30993442
-
Relationship between Hemoglobin Concentration at Admission with the Incidence of No-Reflow Phenomenon and In-Hospital Mortality in Acute Myocardial Infarction with Elevation of ST Segments in Patients who underwent Primary Percutaneous Coronary Intervention.Int J Angiol. 2022 Feb 12;32(2):106-112. doi: 10.1055/s-0042-1742308. eCollection 2023 Jun. Int J Angiol. 2022. PMID: 37207009 Free PMC article.
-
Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.Kardiol Pol. 2016;74(10):1160-1166. doi: 10.5603/KP.a2016.0065. Epub 2016 May 10. Kardiol Pol. 2016. PMID: 27160177
-
Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.Am J Cardiol. 2014 Aug 1;114(3):342-7. doi: 10.1016/j.amjcard.2014.04.045. Epub 2014 May 15. Am J Cardiol. 2014. PMID: 24948493
-
Co-relation of Monocyte Count in High vs. Low Thrombus Burden ST-Segment Elevated Myocardial Infarction (STEMI) Patients Undergoing Primary Percutaneous Coronary Intervention.Cureus. 2022 Apr 21;14(4):e24344. doi: 10.7759/cureus.24344. eCollection 2022 Apr. Cureus. 2022. PMID: 35607551 Free PMC article.
References
-
- Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Harjola VP, Parissis J, Bauersachs J, et al. Eur J Heart Fail. 2020;22:1298–1314. - PubMed
-
- Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE) Steg PG, Dabbous OH, Feldman LJ, et al. Circulation. 2004;109:494–499. - PubMed
-
- Acute heart failure with and without concomitant acute coronary syndromes: patient characteristics, management, and survival. Tarvasmäki T, Harjola VP, Nieminen MS, Siirilä-Waris K, Tolonen J, Tolppanen H, Lassus J. J Card Fail. 2014;20:723–730. - PubMed
LinkOut - more resources
Full Text Sources